Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors
This was the stock's sixth consecutive day of losses.
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing assets from BioReference Health (OPK) for $192.5M, with an ...
Zacks Investment Research on MSN7d
Should Labcorp Stock Stay in Your Portfolio Right Now?
Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.
Hosted on MSN25d
Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy ...
Labcorp, Opko Health acquire certain assets of BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...
PharmiWeb2d
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality
The subdued stock price reaction suggests that Labcorp Holdings Inc.'s ( NYSE:LH ) strong earnings didn't offer ...
Labcorp price target raised to $290 from $260 at Argus
Argus analyst David Toung raised the firm’s price target on Labcorp (LH) to $290 from $260 and keeps a Buy rating on the shares after its Q4 ...